|
Volumn 147, Issue 1, 2011, Pages 123-126
|
Neurogenic rosacea: A distinct clinical subtype requiring a modified approach to treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
AMOXICILLIN;
CAPSAICIN;
CLONIDINE;
DESONIDE;
DOXEPIN;
DOXYCYCLINE;
DULOXETINE;
GABAPENTIN;
GLYCOPYRRONIUM BROMIDE;
HYDROXYCHLOROQUINE;
KETAMINE;
KETOPROFEN;
MEMANTINE;
METRONIDAZOLE;
MINOCYCLINE;
NORTRIPTYLINE;
PRAZOSIN;
PREGABALIN;
PROPRANOLOL;
STEROID;
TETRACYCLINE;
TITANIUM DIOXIDE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADULT;
ARTICLE;
BURNING SENSATION;
CLINICAL ARTICLE;
DRUG EFFICACY;
ERYTHEMA;
FACE EDEMA;
FEMALE;
HUMAN;
MALE;
NEUROGENIC ROSACEA;
PAPULE;
PRIORITY JOURNAL;
PRURITUS;
ROSACEA;
TELANGIECTASIA;
ADOLESCENT;
ADULT;
DERMATOLOGIC AGENTS;
ERYTHEMA;
FACE;
FEMALE;
HOSPITALS, TEACHING;
HUMANS;
MALE;
MIDDLE AGED;
NERVOUS SYSTEM DISEASES;
ROSACEA;
YOUNG ADULT;
|
EID: 78751514984
PISSN: 0003987X
EISSN: 15383652
Source Type: Journal
DOI: 10.1001/archdermatol.2010.413 Document Type: Article |
Times cited : (74)
|
References (5)
|